How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team
Author(s) -
Yalei Zhang,
Jianfei Shen,
Charles B. Simone,
Federico Cappuzzo,
Kwun M. Fong,
Rafael Rosell,
Joe Y. Chang,
Luca Ampollini,
J. Isabelle Choi,
Jianxing He,
Tao Jiang
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.06.101
Subject(s) - medicine , oncology , lung cancer , adenocarcinoma , vinorelbine , stage (stratigraphy) , radiation therapy , adjuvant therapy , sabr volatility model , chemotherapy , cancer , cisplatin , paleontology , biology , volatility (finance) , stochastic volatility , financial economics , economics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom